Sarcomas of the head and neck

Area of Science:

• Oncology
• Pathology
• Surgical Oncology

Background:

• Soft tissue sarcomas (STS) rarely occur in the head and neck, excluding pediatric rhabdomyosarcomas (RMS).
• STS exhibit diverse histology due to their mesenchymal origin, complicating diagnosis and treatment for head and neck oncologists.
• Experienced pathologists are essential for accurate diagnosis and grading of STS.

Purpose of the Study:

• To review the challenges and current management strategies for soft tissue sarcomas in the head and neck region.
• To highlight the importance of accurate pathological classification and grading for prognosis.
• To discuss the role of combined modality therapy in treating high-grade STS.

Main Methods:

• Review of existing literature on head and neck soft tissue sarcomas.
• Discussion of classification schemes based on tumor grade.
• Analysis of treatment modalities including surgery, radiotherapy, and chemotherapy.

Main Results:

• Local control is critical for both high- and low-grade STS, with high-grade tumors having a significant risk of distant metastasis.
• Head and neck STS have lower regional metastasis rates compared to other head and neck neoplasms.
• Treatment strategies vary based on tumor grade, resectability, and specific subtypes like RMS and angiosarcoma.

Conclusions:

• Accurate pathological review and grading are vital for effective STS management.
• Combined modality therapy, incorporating surgery, radiotherapy, and chemotherapy, is often necessary for high-grade and extensive tumors.
• Advances in reconstructive surgery and understanding molecular pathogenesis will improve future treatment and prognostication.